Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study-Reference-Cited by-同舟云学术

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study

Published:2024-05 Issue: Volume:40 Page:100887
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Mihaylova Borislava^ORCID,Wu Runguo^ORCID,Zhou Junwen^ORCID,Williams Claire,Schlackow Iryna,Emberson Jonathan,Reith Christina,Keech Anthony,Robson John,Parnell Richard,Armitage Jane,Gray Alastair,Simes John,Baigent Colin

Publisher

Elsevier BV

Reference33 articles.

1. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015;Roth;J Am Coll Cardiol,2017

2. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Lancet,2010

3. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials;Lancet,2012

4. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur Heart J,2021

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of Cardiology/American heart association task force on clinical practice guidelines;Grundy;Circulation,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study;Heart;2024-09-10